Antineuronal antibodies and 8-OHdG an indicator of cerebellar dysfunction in autism spectrum disorder: a case–control study

References

• Association AP. Diagnostic and statistical manual of mental disorders [DSM-5®]. American Psychiatric Publishing; 2013.
   Google Scholar
• Pop-Jordanova N, Plasevska-Karanfilska D. Autism - genetics, electrophysiology and clinical syndromes. Contrib Acad Sci Arts Sect Biol Med Sci. 2014;35(1):133–146.
   Google Scholar
• Skefos J, Cummings C, Enzer K, et al. Regional alterations in Purkinje cell density in patients with autism. PLoS One. 2014;9(2):e81255. doi: 10.1371/journal.pone.0081255
   Web of Science ®Google Scholar
• Fatemi SH, Aldinger KA, Ashwood P, et al. Consensus paper: Pathological role of the cerebellum in autism. Cerebellum. 2012;11(3):777–807. doi: 10.1007/s12311-012-0355-9
   PubMed Web of Science ®Google Scholar
• Klein AP, Ulmer JL, Quinet SA, et al. Nonmotor functions of the cerebellum: An introduction. Am. J. Neuroradiol. 2016;37(6):1005–1009. doi: 10.3174/ajnr.A4720
   Web of Science ®Google Scholar
• Schmahmann JD, Rosene DL, Pandya DN. Motor projections to the basis pontis in rhesus monkey. J Comp Neurol. 2004;478(3):248–268. doi: 10.1002/cne.20286
   Web of Science ®Google Scholar
• Fournier KA, Hass CJ, Naik SK, et al. Motor coordination in autism spectrum disorders: A synthesis and meta-analysis. J Autism Dev Disord. 2010;40(10):1227–1240. doi: 10.1007/s10803-010-0981-3
   PubMed Web of Science ®Google Scholar
• Nowinski CV, Minshew NJ, Luna B, et al. Oculomotor studies of cerebellar function in autism. Psychiatry Res. 2005;137(1-2):11–19. doi: 10.1016/j.psychres.2005.07.005
   PubMed Web of Science ®Google Scholar
• Hanaie R, Mohri I, Kagitani-Shimono K, et al. Aberrant cerebellar-cerebral functional connectivity in children and adolescents with autism spectrum disorder. Front. Hum. Neurosci. 2018;12:454. doi: 10.3389/fnhum.2018.00454
   PubMed Web of Science ®Google Scholar
• Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543–1554. doi: 10.1056/NEJMra023009
   PubMed Web of Science ®Google Scholar
• Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8(7):380–390. doi: 10.1038/nrneurol.2012.99
   PubMed Web of Science ®Google Scholar
• Ogita S, Llaguna OH, Feldman SM, et al. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: A case report with a current literature review. Breast J. 2008;14(4):382–384. doi: 10.1111/j.1524-4741.2008.00604.x
   Web of Science ®Google Scholar
• Hirunagi T, Sato K, Fujino M, et al. Subacute cerebellar ataxia with amphiphysin antibody developing in a patient with follicular thyroid adenoma: a case report. Rinsho Shinkeigaku. 2016;56(11):769–772. doi: 10.5692/clinicalneurol.cn-000939
   Google Scholar
• Ali NH, Khalaf SK, Al-Asadi JN, et al. Maternal antineuronal antibodies and risk of childhood autism spectrum disorders: A case–control study. J Chinese Med Assoc. 2016;79(12):661–664. doi: 10.1016/j.jcma.2016.08.003
   PubMed Web of Science ®Google Scholar
• Lovell MA, Markesbery WR. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. Mart. 2001;58(3):392–396.
   Google Scholar
• Kikuchi A, Takeda A, Onodera H, et al. Systemic increase of oxidative nucleic acid damage in Parkinson’s disease and multiple system atrophy. Neurobiol Dis. 2002;9(2):244–248. doi: 10.1006/nbdi.2002.0466
   PubMed Web of Science ®Google Scholar
• Nishioka N, Arnold SE. Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry. 2004;12(2):167–175. doi: 10.1097/00019442-200403000-00008
   PubMed Web of Science ®Google Scholar
• Fukuda M, Yamauchi H, Yamamoto H, et al. The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels. Brain Dev. 2008;30(2):131–136. doi: 10.1016/j.braindev.2007.07.005
   Web of Science ®Google Scholar
• Sajdel-Sulkowska EM, Xu M, Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum. 2009;8(3):366–372. doi: 10.1007/s12311-009-0105-9
   PubMed Web of Science ®Google Scholar
• Melnyk S, Fuchs GJ, Schulz E, et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord. 2012;42(3):367–377. doi: 10.1007/s10803-011-1260-7
   PubMed Web of Science ®Google Scholar
• Ming X, Stein TP, Brimacombe M, et al. Increased excretion of a lipid peroxidation biomarker in autism. Prostag Leukot Essent Fat Acids. 2005;73(5):379–384. doi: 10.1016/j.plefa.2005.06.002
   Web of Science ®Google Scholar
• Schopler E, Reichler RJ, Rochen Renner B. The Childhood Autism Rating Scale (CARS), Western Psychological Services; 2007; 11.
   Google Scholar
• Robert J, Reichler RJ, Rochen Renner B, et al. Practice DVD on using the CARS, Western Psychological Services. 1988.
   Google Scholar
• Garfin DG, Mc Callon D, Cox R. Validity and relaibility of the childhood autism rating scale with autistic adolescents. J Autism Dev Disord. 1988;18: 367–378. doi: 10.1007/BF02212193
   PubMed Web of Science ®Google Scholar
• Sucuoğlu B, Oktem F, Akkök F, et al. A study of the scales for the assessment of the children with autism. 3P Derg. 1996;4(2):116–121.
   Google Scholar
• Karim A, Hughes R, El-Lahawi M, et al. Paraneoplastic neurological antibodies. Shoenfeld Y, Gershwin ME MP, editör. Elsevier 2007; 627–652.
   Google Scholar
• Schmahmann J. The cerebellum and Cognition. SanDiego: Academic Press; 1997; 41(1): 665–666.
   Google Scholar
• Greenfield J. The spino-cerebellar degenerations. Illinois: Springfield; 1954.
   Google Scholar
• DeBassio WA, Kemper TL, Knoefel JE. Coffin-Siris syndrome: Neuropathologic findings. Arch Neurol. 1985;42(4):350–353. doi: 10.1001/archneur.1985.04060040060012
   PubMedGoogle Scholar
• Kemper TL. The developmental neuropathology of autism. In: Blatt GJ, editor. The neurochemical basis of autism. Boston, MA: Springer; 2010. p. 69–82. doi: 10.1007/978-1-4419-1272-5_5
   Google Scholar
• Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol. 1998;57(7):645–652. doi: 10.1097/00005072-199807000-00001
   PubMed Web of Science ®Google Scholar
• Courchesne E. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol. 1997;7(2):269–278. doi: 10.1016/S0959-4388(97)80016-5
   Web of Science ®Google Scholar
• Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67–81. doi: 10.1002/ana.20315
   PubMed Web of Science ®Google Scholar
• Nadeem A, Ahmad SF, Al-Harbi NO, et al. Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T + tf/J mice. Prog Neuro-Psychopharm Biol Psychiat. 2019;89:245–253. doi: 10.1016/j.pnpbp.2018.09.012
   Web of Science ®Google Scholar
• Shpyleva S, Ivanovsky S, De Conti A, et al. Cerebellar oxidative DNA damage and altered DNA methylation in the BTBR T + tf/J mouse model of autism and similarities with human post mortem cerebellum. PLoS One. 2014;9(11):e113712. doi: 10.1371/journal.pone.0113712
   Web of Science ®Google Scholar
• Yukus B, Çakır D. Bıomarker of invıivo oxidative DNA damage; 8-hydroxy-2’-deoxyguanosıne. T Klin J Med. 2001;22(5):535–543.
   Google Scholar
• Napoli E, Wong S, Giulivi C. Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Mol Autism. 2013;4(1):2–3. doi: 10.1186/2040-2392-4-2
   Google Scholar
• Yui K, Tanuma N, Yamada H, et al. Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder. Environ Sci Pollut Res. 2017;24(10):9635–9644. doi: 10.1007/s11356-017-8595-3
   Web of Science ®Google Scholar
• Yui K, Tanuma N, Yamada H, et al. Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder. Int J Dev Neurosci. 2017;60:70–77. doi: 10.1016/j.ijdevneu.2016.08.003
   Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. Hoboken, NJ: John Wiley&Sons; 2013.
   Google Scholar
• Metwally FM, Rashad H, Zeidan HM, et al. Study of the effect of bisphenol A on oxidative stress in children with autism spectrum disorders. Indian J Clin Biochem. 2018;33(2):196–201. doi: 10.1007/s12291-017-0667-0
   PubMed Web of Science ®Google Scholar
• Wang L, Jia J, Zhang J, et al. Serum levels of SOD and risk of autism spectrum disorder: A case-control study. Int J Dev Neurosci. 2016;51:12–16. doi: 10.1016/j.ijdevneu.2016.04.004
   Web of Science ®Google Scholar